Home › Gambro Dialysatoren GmbH › Adsorba Hemoperfusion cartridge
Adsorba Hemoperfusion cartridge
Gambro Dialysatoren GmbH · Model 150C · UDI-DI 07332414015480
FLD
Prescription
10
510(k) clearances
50
Adverse events (1 deaths)
7
Recalls
11
Facilities
Description
The Adsorba 150C hemoperfusion cartridge is a steam sterilized device which contains 150 grams of cellulose-coated activated charcoal. The device is filled with physiological saline solution prior to sterilization.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2017-12-21 | Baxter Healthcare Corporation | Baxter has received customer complaints regarding leakage in the albumin circuit. The leakage was caused by an inadequate adhesive connection of the tubing to the Hansen connector |
| 2014-07-18 | Gambro Renal Products, Incorporated | Gambro initiated a field action on the Prisma and Prismaflex sets due to breakages of connectors resulting in leakage of liquid or blood. |
| 2014-07-18 | Gambro Renal Products, Incorporated | Gambro initiated a field action on the Prisma and Prismaflex sets due to breakages of connectors resulting in leakage of liquid or blood. |
| 2007-01-19 | Clark Research and Development Inc | Lack of sterility assurance based on lack of sterility validation for labeled sterilization directions |
| 2007-01-19 | Clark Research and Development Inc | Lack of sterility assurance based on lack of sterility validation for labeled sterilization directions |
| 2007-01-19 | Clark Research and Development Inc | Lack of sterility assurance based on lack of sterility validation for labeled sterilization directions |
| 2007-01-19 | Clark Research and Development Inc | Lack of sterility assurance based on lack of sterility validation for labeled sterilization directions |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.